Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital...

Thursday July 17, 9:24 am ET YOKNEAM, Israel, July 17 /PRNewswire/ -- Arbel Medical, an Israeli start-up developing the next generation of medical equipment for removing tumors by freezing (cryotherapy), has completed raising $4.5 million of capital in its second round, led by the Giza Venture Capital fund. The Docor International investment company, of the Van Leer group, has invested $1 million, joining the other Arbel investors who include Giza Venture Capital, Ofer High Tech, the Bridge Investment Fund from the USA, TRD and Fattal. Dr Alon Dumanis, CEO of Docor, will be appointed as a member of the Board of Directors of Arbel Medical. Arbel Medical works in the field of minimal-invasive treatments. The company is developing next generation medical devices for removing tumors by freezing (cryotherapy). Cryotherapy is... [read full story]